Literature DB >> 20407273

Albuminuria among Alaska Natives--findings from the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study.

Stacey E Jolly1, Carolyn J Noonan, Yvette D Roubideaux, Jack H Goldberg, Sven O E Ebbesson, Jason G Umans, Barbara V Howard.   

Abstract

BACKGROUND: The prevalence and associated risk factors for albuminuria and low-grade albuminuria in Alaska Natives is not known.
METHODS: Cross-sectional analysis of the Genetics of Coronary Artery Disease in Alaska Natives Study. We included 1,026 individuals, who represent 85% of the study participants for whom complete data were available. Risk factors examined were age, sex, education, diabetes, hypertension, obesity, lipids, C-reactive protein, angiotensin-converting enzyme inhibitor use, and smoking status. Urine albumin excretion was estimated by the albumin/creatinine ratio measured from a single random morning urine sample. Albuminuria was defined as an albumin/creatinine ratio of > or =30 mg/g. Low-grade albuminuria was defined as an albumin/creatinine ratio of 10 to <30 mg/g.
RESULTS: The mean age was 42 years and over half were female. Diabetes prevalence was low at 3% and the prevalence of hypertension was 20%. The prevalence of albuminuria was 6%; the prevalence of low-grade albuminuria was 12%. Individuals with diabetes or hypertension were 3 times more likely to have albuminuria than those without these conditions [odd ratios: diabetes 3.0 (1.2-7.9) and hypertension 3.0 (1.2-7.3)].
CONCLUSIONS: The burden of albuminuria is low. Comprehensive programs and policies are important given the rise in diabetes and hypertension among Alaska Natives. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20407273      PMCID: PMC2892647          DOI: 10.1159/000312873

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  34 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Albuminuria in recent-onset type 2 diabetes: the Strong Heart Study.

Authors:  Jay M Sosenko; Dongsheng Hu; Tom Welty; Barbara V Howard; Elisa Lee; David C Robbins
Journal:  Diabetes Care       Date:  2002-06       Impact factor: 19.112

3.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

4.  Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population.

Authors:  Hans L Hillege; Vaclav Fidler; Gilles F H Diercks; Wiek H van Gilst; Dick de Zeeuw; Dirk J van Veldhuisen; Rijk O B Gans; Wilbert M T Janssen; Diederick E Grobbee; Paul E de Jong
Journal:  Circulation       Date:  2002-10-01       Impact factor: 29.690

5.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

Authors:  Thomas A Pearson; George A Mensah; R Wayne Alexander; Jeffrey L Anderson; Richard O Cannon; Michael Criqui; Yazid Y Fadl; Stephen P Fortmann; Yuling Hong; Gary L Myers; Nader Rifai; Sidney C Smith; Kathryn Taubert; Russell P Tracy; Frank Vinicor
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

Review 6.  Albuminuria: moving beyond traditional microalbuminuria cut-points.

Authors:  Eric L Knight; Gary C Curhan
Journal:  Curr Opin Nephrol Hypertens       Date:  2003-05       Impact factor: 2.894

7.  Association of the insulin resistance syndrome and microalbuminuria among nondiabetic native Americans. The Inter-Tribal Heart Project.

Authors:  Christine M Hoehner; Kurt J Greenlund; Stephen Rith-Najarian; Michele L Casper; William M McClellan
Journal:  J Am Soc Nephrol       Date:  2002-06       Impact factor: 10.121

8.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Authors:  H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

9.  Epidemic of diabetic and nondiabetic renal disease among the Zuni Indians: the Zuni Kidney Project.

Authors:  Vallabh O Shah; Marina Scavini; Christine A Stidley; Francesca Tentori; Thomas K Welty; Jean W MacCluer; Andrew S Narva; Arlene Bobelu; Carleton P Albert; David S Kessler; Antonia M Harford; Craig S Wong; Alexis A Harris; Susan Paine; Philip G Zager
Journal:  J Am Soc Nephrol       Date:  2003-05       Impact factor: 10.121

10.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

View more
  3 in total

1.  Uric acid, hypertension, and chronic kidney disease among Alaska Eskimos: the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study.

Authors:  Stacey E Jolly; Mihriye Mete; Hong Wang; Jianhui Zhu; Sven O E Ebbesson; V Saroja Voruganti; Anthony G Comuzzie; Barbara V Howard; Jason G Umans
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-01-04       Impact factor: 3.738

2.  Racial and ethnic differences in mortality among individuals with chronic kidney disease: results from the Kidney Early Evaluation Program (KEEP).

Authors:  Stacey E Jolly; Nilka Ríos Burrows; Shu-Cheng Chen; Suying Li; Claudine T Jurkovitz; Keith C Norris; Michael G Shlipak
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 8.237

3.  Cardiovascular Disease Among Alaska Native Peoples.

Authors:  Stacey E Jolly; Barbara V Howard; Jason G Umans
Journal:  Curr Cardiovasc Risk Rep       Date:  2013-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.